Breast Cancer News and Research

Latest Breast Cancer News and Research

Younger postmenopausal women may not get enough calcium

A small Italian study examined whether women facing heightened bone-loss risks are getting enough calcium from their diets, with particular attention to breast cancer patients receiving endocrine therapy.

6 Oct 2026

Phase III trial tests MRD-guided treatment for patients with ER-positive/HER2-negative breast cancer

Alliance Foundation Trials, LLC (AFT), a national leader in conducting innovative, practice-changing cancer clinical trials, and Natera, Inc., a global leader in cell-free DNA and precision medicine, today announced the launch of AFT-70 NAVIGATE, a randomized phase III trial evaluating a novel molecular residual disease (MRD)-guided treatment strategy for patients with intermediate and high-risk ER-positive/HER2-negative early breast cancer.

5 Oct 2026

Tailored treatments allow less invasive surgery for breast cancer patients

For many patients diagnosed with breast cancer, the first instinct may be to pursue the most aggressive treatment possible.

5 Oct 2026

Working nights for years is linked to changes in body-clock genes

Chronic night shifts alter circadian gene activity in female healthcare workers.

5 Oct 2026

Nuclear enzyme discovery unlocks new paths to combat breast cancer

One of the major challenges in the treatment of the most common subtype of breast cancer (hormone receptor positive, HR+) is the emergence of resistance.

30 Sep 2026

Label-free microfluidic chip and AI identify blood-borne tumor cells

Finding a few tumor cells hidden among billions of blood cells is one of the biggest challenges in liquid biopsy.

30 Sep 2026

Exercise linked to better attention and memory after breast cancer

One in three breast cancer survivors will experience cognitive problems, which can include difficulties with attention, memory, processing speed and other aspects of thinking.

29 Sep 2026

Blood tests can identify cancer neoantigens for personalized immunotherapy

Cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells, respectively, and they largely matched those found through traditional tumor tissue biopsy in many patients.

29 Sep 2026

Late diagnosis and systemic gaps drive high cancer death rates in the Balkans

In the Balkans, cancer survival rates lag due to late diagnoses and weak screening programs, highlighting the need for improved early detection strategies.

From BGI Genomics 29 Sep 2026

Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns

HR+/HER2− breast cancer constitutes approximately 65–75% of all breast cancer cases worldwide. Although CDK4/6 inhibitors have substantially extended progression-free survival (PFS), up to 60% of patients derive no clinical benefit from these agents, underscoring the urgent need for more effective therapeutic strategies.

28 Sep 2026

Long-term endocrine therapy adherence remains low after breast cancer surgery

Many patients with early-stage breast cancer do not consistently maintain the long-term hormone therapy prescribed after lumpectomy, a large U.S. insurance claims analysis indicates.

27 Sep 2026

EGFR co-targeting and nanotechnology offer new triple-negative breast cancer therapies

Triple-negative breast cancer (TNBC) remains one of the most challenging forms of breast cancer to treat because it lacks the estrogen, progesterone and HER2 receptors that enable targeted treatment in other breast cancer subtypes.

24 Sep 2026

New multimodal AI model improves breast cancer screening accuracy

Breast cancer screening must balance diagnostic accuracy with workflow throughput. DM remains the traditional cornerstone, but its two-dimensional projection creates tissue-overlap noise, particularly in dense breasts, leading to false positives and obscured lesions.

24 Sep 2026

New trial aims to evaluate chemotherapy benefit for ER+/HER2- breast cancer patients

The addition of CDK4/6 inhibitors to endocrine therapy has changed the standard of care for patients with high-risk early-stage estrogen receptor-positive, HER2-negative (ER+/HER2-) breast cancer by reducing the risk of recurrence.

24 Sep 2026

New AI tool detects signs of endometriosis in milliseconds

Less than a second. That's how long it takes for an emerging AI tool to detect signs of endometriosis through one simple scan.

23 Sep 2026

Roche advances the Africa Breast Cancer Ambition to power economic growth and transform healthcare across Africa

As global leaders gather for Unstoppable Africa 2026, Roche (www.Roche.com) has reaffirmed its commitment to advancing healthcare as a primary driver of economic resilience across the continent.

23 Sep 2026

Cancer-related DNA changes may appear in blood years before diagnosis

Researchers found that genome-wide plasma cfDNA methylation profiles collected before diagnosis contained early molecular signatures associated with future prostate and breast cancer, with prostate silencer methylation providing the stronger risk stratification. Breast enhancer signals were weaker and varied by subtype and disease stage, indicating that cfDNA methylation may have greater value for risk assessment and surveillance than as a standalone diagnostic test.

23 Sep 2026

Cancer incidence rises faster among people with type 2 diabetes

A nationwide study being presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) has found that people with type 2 diabetes (T2D) have a higher risk of developing cancer, with cancer incidence rising more among people with T2D than those without diabetes over the past 25 years, largely driven by obesity-related cancers.

22 Sep 2026

Simple prompts may improve cancer screening compliance among high-risk groups

People getting recommended screening tests for one cancer can be reminded about other relevant screenings. It's a simple way to increase compliance for potentially life-saving tests.

22 Sep 2026